Intezyne Technologies
Tampa
About Intezyne Technologies
Intezyne Technologies, Inc., a biomedical research company, engages in developing synthetic polymers for drug delivery and the treatment of cancer. The company develops IVECT Method to limit chemotherapeutics' anti-tumor activity to within the tumor itself. Its IVECT Method could deliver various classes of small molecules, nucleic acids, oligopeptides, and diagnostic imaging agents. Intezyne Technologies was founded in 2004...
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2017)
- Website: intezyne.com
- Phone: 8139102120
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/intezyne-technologies-6836 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.